These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6644887)

  • 1. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin and urokinase.
    Lundbeck F; Mogensen P; Jeppesen N
    J Urol; 1983 Dec; 130(6):1087-9. PubMed ID: 6644887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin: initial treatment results and the long-term course.
    Lundbeck F; Bruun E; Finnerup B; Christophersen IS
    J Urol; 1988 Jun; 139(6):1212-3. PubMed ID: 3373590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
    Garnick MB; Schade D; Israel M; Maxwell B; Richie JP
    J Urol; 1984 Jan; 131(1):43-6. PubMed ID: 6690745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial.
    Zincke H; Utz DC; Taylor WF; Myers RP; Leary FJ
    J Urol; 1983 Mar; 129(3):505-9. PubMed ID: 6403716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.
    Scher HI; Yagoda A; Herr HW; Sternberg CN; Bosl G; Morse MJ; Sogani PC; Watson RC; Dershaw DD; Reuter V
    J Urol; 1988 Mar; 139(3):470-4. PubMed ID: 3343728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
    Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
    J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intravesical therapy with doxorubicin (adriamycin) and urokinase in the management of superficial bladder tumours.
    Khan O; Aherne GW; Williams G
    Br J Urol; 1982 Jun; 54(3):280-2. PubMed ID: 7049304
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
    Lamm DL; Blumenstein BA; Crawford ED; Montie JE; Scardino P; Grossman HB; Stanisic TH; Smith JA; Sullivan J; Sarosdy MF
    N Engl J Med; 1991 Oct; 325(17):1205-9. PubMed ID: 1922207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical pericystitis: a severe complication of the intravesical instillation of adriamycin].
    Ricos Torrent JV; Mazcuñán Fuentes F; Iborra Juan I; Casanova Ramón-Borja J; Monrós Lliso JL; Cervera Deval J; Solsona Narbón E
    Arch Esp Urol; 1988; 41(9):891-4. PubMed ID: 3228316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report)].
    Fukui I; Sekine H; Yamada T; Kihara K
    Hinyokika Kiyo; 1985 Apr; 31(4):623-6. PubMed ID: 3929577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation therapy with adriamycin for bladder cancer in the Korean study group.
    Kim SK; An HJ; Cho JH
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S22-4. PubMed ID: 6640831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.
    Cheng CW; Chan PS; Chan LW; Chan CK; Ng CF; Lai MM
    Int Braz J Urol; 2005; 31(3):204-11. PubMed ID: 15992422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of adriamycin.
    Ohi Y; Okamoto K; Kawabata T; Hanafusa A; Fai CY; Kakinoki T; Kawahara M; Asechi S; Sakamoto N; Nagata S
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S83-8. PubMed ID: 6640840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of doxorubicin hydrochloride during bladder washings in treatment of noninvasive bladder tumors.
    Lundbeck F; Pedersen D; Stroyer I; Uldall A
    Urology; 1981 Aug; 18(2):161-3. PubMed ID: 7269019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.
    Fukui I; Sekine H; Kihara K; Yamada T; Takeuchi S; Yokokawa M; Kawai T; Hosoda K; Ohwada F; Suzuki S
    J Urol; 1989 Mar; 141(3):531-4. PubMed ID: 2493099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravesical chemotherapy with 4'-EPI-adriamycin in patients with superficial bladder tumors (randomized study)].
    Tsushima T; Matsumura Y; Ozaki Y; Akagi T; Obama T; Nasu Y; Ohmori H
    Hinyokika Kiyo; 1985 Dec; 31(12):2215-8. PubMed ID: 3868934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.
    Logothetis CJ; Dexeus FH; Chong C; Sella A; Ayala AG; Ro JY; Pilat S
    J Urol; 1989 Jan; 141(1):33-7. PubMed ID: 2908950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical pericystitis: a rare complication of intravesical doxorubicin.
    Yoshimura A; Ogawa A; Wajiki M; Yoneyama T
    J Urol; 1986 Jun; 135(6):1237-9. PubMed ID: 3712578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.